End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.3 TWD | +0.74% | -2.64% | -19.76% |
Apr. 15 | Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only | CI |
Mar. 21 | Applied BioCode Announces CEO Changes | CI |
Sales 2024 * | 430M 13.31M | Sales 2025 * | - | Capitalization | 1.66B 51.39M |
---|---|---|---|---|---|
Net income 2024 * | -145M -4.49M | Net income 2025 * | - | EV / Sales 2024 * | 3.86 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-11.4
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 100% |
1 day | +0.74% | ||
1 week | -2.64% | ||
Current month | +0.74% | ||
1 month | +2.78% | ||
3 months | -11.16% | ||
6 months | -14.35% | ||
Current year | -19.76% |
Managers | Title | Age | Since |
---|---|---|---|
Zonh Zen Ho
CEO | Chief Executive Officer | - | 07-12-31 |
Liang Kai Huang
DFI | Director of Finance/CFO | - | 18-01-31 |
Cassandra Ingles
CTO | Chief Tech/Sci/R&D Officer | - | 23-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Lee
CHM | Chairman | 73 | 16-06-29 |
Benjamin Jen
BRD | Director/Board Member | 58 | 16-09-28 |
Wen Ching Tsai
BRD | Director/Board Member | - | 16-09-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-02 | 20.3 | +0.74% | 25 307 |
24-05-31 | 20.15 | -0.98% | 86,253 |
24-05-30 | 20.35 | -0.73% | 66,998 |
24-05-29 | 20.5 | -0.73% | 94,066 |
24-05-28 | 20.65 | -0.24% | 42,660 |
End-of-day quote Taiwan S.E., June 02, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.76% | 50.66M | |
-39.90% | 8.39B | |
+1.42% | 3.32B | |
+6.22% | 2.48B | |
-19.81% | 2.06B | |
-23.77% | 1.59B | |
+34.89% | 1.15B | |
-7.21% | 704M | |
+10.58% | 678M | |
-30.10% | 508M |
- Stock Market
- Equities
- 6598 Stock